china digital currency yuan price searches

Treasury futures closed in early trading, with the main contract of 2-year Treasury futures (TS) falling by 0.06%, 5-year Treasury futures (TF) falling by 0.13%, 10-year Treasury futures (T) falling by 0.15% and 30-year Treasury futures (TL) falling by 0.26%.Can TCL make a three-fold mobile phone? Li Dongsheng responded: We have the technology, depending on the needs of the market. At the TCL Global Technology Innovation Conference held today, Li Dongsheng, the founder and chairman of TCL, attended the conference for the 11th time and made a live speech. At this conference, TCL exhibited and introduced the first Tandem three-fold screen (7.85 ") developed by the company. The folding screen can support "G-shaped" or "Z-shaped" folding, and combines Tandem, LTPO and PLP multiple low-power technologies to realize comprehensive promotion of high brightness, low power consumption and long service life. Will TCL launch three-fold mobile phones and other products? In the communication with Sina Technology, Li Dongsheng responded that "we have such technology", but we need to "see the market needs" whether to launch related products. (Sina Technology)The share price was 6 consecutive boards, and Shandong Fiberglass responded. On December 11th, the share price of Shandong Fiberglass went up again. Since December 4, the company's share price has been up and down for six consecutive trading days. In response to the abnormal fluctuation of the stock price, the reporter called Shandong Glass Fiber, and the company responded: "At present, the company's production and operation are all normal, and there is no significant information that should be disclosed but not disclosed. The short-term sharp fluctuation of stock price may be caused by overheated market sentiment. We remind investors that they should invest prudently and make rational decisions to avoid blindly chasing up. " (CSI Taurus)

Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Local regulators have found out the situation of institutions purchasing unlicensed financial information service products. The reporter was informed that some local securities regulatory bureaus are finding out the situation of institutions purchasing unlicensed financial information service products. The regulatory requirements require the securities fund and futures-related operating institutions within their jurisdiction to self-inspect the purchase of foreign financial information service products without the permission of the National Network Information Office. The main contents include a brief description of financial information service products, the contact telephone number and email address of foreign institutions, and so on. According to relevant regulations, the provision of financial information services by foreign institutions in China must be approved. Up to now, a total of 31 foreign institutions and 10 enterprises invested and established by foreign institutions in China have been licensed to provide financial information services. (Cailian)Volvo Cars: The Daqing plant has rolled off 500,000 vehicles.

President of Japan Life Insurance: In a growing market, Resolution Life is an excellent company, so we hope to ensure its potential together. Note: Japan Life Insurance announced on December 11th that it will spend about US$ 8.2 billion to acquire the remaining 77% shares of Resolution Life.China strongly condemns Canada's illegal sanctions against relevant Chinese personnel. On the 10th, a spokesman for the Chinese Embassy in Canada said that the Canadian Ministry of Foreign Affairs, under the pretext of so-called human rights, had planted and smeared China and announced that it had imposed illegal sanctions on relevant Chinese personnel, which seriously violated international law and the basic norms of international relations and seriously interfered in China's internal affairs. China firmly opposed this and strongly condemned it. (Xinhua News Agency)Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.